New drug aims to calm lupus kidney attacks
Disease control
Ongoing
This study tests a new drug, felzartamab, in 14 people with active lupus nephritis (kidney inflammation caused by lupus). The drug targets immune cells that make harmful antibodies, which build up in the kidneys and cause damage. Participants continue their usual treatments while…
Phase: PHASE1 • Sponsor: HI-Bio, A Biogen Company • Aim: Disease control
Last updated May 17, 2026 10:06 UTC